Overview
Douglas Blayney is an Oncologist in Stanford, California. Dr. Blayney is rated as an Elite provider by MediFind in the treatment of Agranulocytosis. His top areas of expertise are Agranulocytosis, Breast Cancer, Febrile Neutropenia, Angiosarcoma, and Prostatectomy.
His clinical research consists of co-authoring 98 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles in the study of Agranulocytosis.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Regents Of The University Of California
Hope Rugo is a Hematologist and an Oncologist in San Francisco, California. Dr. Rugo is rated as an Elite provider by MediFind in the treatment of Agranulocytosis. Her top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Agranulocytosis, Bone Marrow Aspiration, and Hormone Replacement Therapy (HRT).
Stanford Health Care
Rishi Sawhney is an Oncologist and a Hematologist Oncology provider in Stanford, California. Dr. Sawhney is rated as a Distinguished provider by MediFind in the treatment of Agranulocytosis. His top areas of expertise are Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Iron Deficiency Anemia.
Karen Chee is an Oncologist in San Mateo, California. Dr. Chee is rated as a Distinguished provider by MediFind in the treatment of Agranulocytosis. Her top areas of expertise are Febrile Neutropenia, Non-Hodgkin Lymphoma, Chronic Familial Neutropenia, and Agranulocytosis.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- AgranulocytosisDr. Blayney isElite. Learn about Agranulocytosis.
- Distinguished
- AngiosarcomaDr. Blayney isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Blayney isDistinguished. Learn about Breast Cancer.
- Febrile NeutropeniaDr. Blayney isDistinguished. Learn about Febrile Neutropenia.
- Inflammatory Breast CancerDr. Blayney isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Blayney isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Breast Cancer in MenDr. Blayney isAdvanced. Learn about Breast Cancer in Men.
- Experienced
- Familial Prostate CancerDr. Blayney isExperienced. Learn about Familial Prostate Cancer.
- HER-2 Positive Breast CancerDr. Blayney isExperienced. Learn about HER-2 Positive Breast Cancer.
- Lung CancerDr. Blayney isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Blayney isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Prostate CancerDr. Blayney isExperienced. Learn about Prostate Cancer.
- ProstatectomyDr. Blayney isExperienced. Learn about Prostatectomy.